Warning: The NCBI web site requires JavaScript to function. more...
Impact: a case study examining the closure of a large urban fixed site needle exchange in Canada.
Macneil J, Pauly B.
Harm Reduct J. 2010 May 25;7:11.
Related citations
Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.
Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT.
J Urban Health. 2002 Jun;79(2):257-65.
The impact of a needle exchange's closure.
Broadhead RS, van Hulst Y, Heckathorn DD.
Public Health Rep. 1999 Sep-Oct;114(5):439-47.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
An examination of injection drug use trends in Victoria and Vancouver, BC after the closure of Victoria's only fixed-site needle and syringe programme.
Ivsins A, Chow C, Macdonald S, Stockwell T, Vallance K, Marsh DC, Michelow W, Duff C.
Int J Drug Policy. 2012 Jan 24. [Epub ahead of print]
HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC, Friedman SR.
AIDS. 1987 Jul;1(2):67-76. Review.
The role of needle exchange programs in HIV prevention.
Vlahov D, Junge B.
Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.
An external evaluation of a peer-run "unsanctioned" syringe exchange program.
Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT.
J Urban Health. 2003 Sep;80(3):455-64.
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year.
Hart GJ, Carvell AL, Woodward N, Johnson AM, Williams P, Parry JV.
AIDS. 1989 May;3(5):261-5.
Needle exchange: how the meanings ascribed to needles impact exchange practices and policies.
Strike CJ, Myers T, Millson M.
AIDS Educ Prev. 2002 Apr;14(2):126-37.
Satellite needle distribution among injection drug users: policy and practice in two canadian cities.
Tyndall MW, Bruneau J, Brogly S, Spittal P, O'Shaughnessy MV, Schechter MT.
J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):98-105.
Clean needles save lives. HIV and injecting drug use.
James B.
AIDS Action. 1993 Jun-Aug;(21):4-5.
Harm reduction product distribution in British Columbia.
Harvard SS, Hill WD, Buxton JA.
Can J Public Health. 2008 Nov-Dec;99(6):446-50.
Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J, Desenclos JC.
Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.
The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
Myers T, Cockerill R, Millson M, Rankin J, Worthington C.
AIDS Public Policy J. 1996 Summer;11(2):78-88.
Needle-exchange in central London: operating philosophy and communication strategies.
Hart G, Woodward N, Carvell A.
AIDS Care. 1989;1(2):125-34.
Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
Matheson C, Bond CM, Tinelli M.
J Public Health (Oxf). 2007 Dec;29(4):350-7. Epub 2007 Nov 6.
Social context of needle selling in Baltimore, Maryland.
Latkin CA, Davey MA, Hua W.
Subst Use Misuse. 2006;41(6-7):901-13.
Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A, Rhodes T, Platt L.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. Epub 2008 Mar 3.
Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses.
Hutchinson SJ, Taylor A, Goldberg DJ, Gruer L.
Addiction. 2000 Jun;95(6):931-40.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on